Questionary survey of the percentage of inoculation of the influenza vaccine during the cancer duration of treatment

Questionary survey of the percentage of inoculation of the influenza vaccine during the cancer duration of treatment - Questionary survey of the percentage of inoculation of the influenza vaccine during the cancer duration of treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030646

Enrollment

Registered

2018-01-01

Start date

2017-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

all cancers

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients with cancer

Exclusion criteria

Exclusion criteria: The drug that influenza vaccine is contraindicated is given

Design outcomes

Primary

Measure	Time frame
We examine frequency how you took in influenza vaccine by questionary survey during cancer duration of treatment	—

Countries

Japan

Contacts

Public ContactOsamu Tanaka

Murakami Memorial hospital Dept.of Radiation Oncology

c.bluered@gmail.com058-252-8001

Outcome results